<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Inoculums development for the production of monoclonal antibody against Congenital Adrenal Hyperplasia (CAH)</title>
  </titleInfo>
  <name type="personal">
    <namePart>Leong, Choon Wei</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">theses</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">my</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Kuantan, Pahang</placeTerm>
    </place>
    <publisher>UMP</publisher>
    <dateIssued>2010</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xv, 69 p. : ill. ; 30 cm. + 1 CD-ROM</extent>
  </physicalDescription>
  <abstract>By now, the importance of inoculums development was well appreciated in  bioprocessing. Inoculums development receives as much care and attention as the  growth and product cycles. The status or “health” of the inoculums has a great deal  to do with the success of the production cycle. In this project, inoculums  development for the production of monoclonal antibody against Congenital Adrenal  Hyperplasia (CAH) was studied. The scopes focused were the age of inoculums  (passage number) and inoculums density at different growth phases. A hybridoma  cell line (Hybridoma 192) was cultivated in batch mode with varying inoculums cell  densities and growth phases using Dulbecco’s Modified Eagle Medium (DMEM).  The maximum viable cell densities and the average specific MAb production rate (rp)  were found to dependent on the inoculums cell density and the growth phases.  Inoculums with low cell density at 5X104cells/ml and early log phase (t=28h) have  the highest average specific MAb production rate but a low maximum viable cell  density. Varying inoculums cell densites and growth phases did not affect the  specific growth rate, maximum MAb titer and net production of MAb. Since the  inoculums density in the range of 5x104 cells/ml to 5x105 cells/ml and growth phase  do not affect the net production of MAb, it is wise to use high initial inoculums cell  density at 5x105 cells/ml because the cell growth easily and faster compare low  inoculums density. For the inoculums age, the average specific MAb production rate  decreased when the passage number increased from PN (Passage Number) =9 to  PN=30.Subculture exceeding critical passage number 9 was thus not recommended.</abstract>
  <targetAudience authority="marctarget">specialized</targetAudience>
  <note type="statement of responsibility">Leong Choon Wei</note>
  <note>Project paper (Bachelor of Chemical Engineering (Biotechnology)) -- Universiti Malaysia Pahang - 2010</note>
  <note>Bibliography : p. 31-33</note>
  <subject authority="lcsh">
    <topic>Monoclonal antibodies</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Biotechnology</topic>
    <topic>Methods</topic>
  </subject>
  <identifier type="isbn">THE0004514(Local)</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">UMP</recordContentSource>
    <recordCreationDate encoding="marc">120109</recordCreationDate>
    <recordChangeDate encoding="iso8601">20251114204509.0</recordChangeDate>
    <recordIdentifier source="KUKTEM">vtls000058166</recordIdentifier>
  </recordInfo>
</mods>
